BRIEF-TG Therapeutics launches first clinical trial in multiple sclerosis
May 03, 2016 at 08:29 AM EDT
* TG Therapeutics, Inc. launches first clinical trial in multiple sclerosis (ms) for tg-1101 (ublituximab) Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
